Revvity ROA 2010-2025 | RVTY
Current and historical return on assets (ROA) values for Revvity (RVTY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Revvity ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.29B | $12.36B | 2.25% |
| 2024-12-31 | $0.27B | $12.39B | 2.08% |
| 2024-09-30 | $0.25B | $12.77B | 1.91% |
| 2024-06-30 | $0.17B | $13.43B | 1.26% |
| 2024-03-31 | $0.15B | $13.43B | 1.10% |
| 2023-12-31 | $0.69B | $13.57B | 4.96% |
| 2023-09-30 | $0.74B | $13.42B | 5.26% |
| 2023-06-30 | $0.82B | $14.22B | 5.76% |
| 2023-03-31 | $0.96B | $14.64B | 6.77% |
| 2022-12-31 | $0.57B | $14.13B | 3.99% |
| 2022-09-30 | $0.63B | $13.82B | 4.36% |
| 2022-06-30 | $0.67B | $14.19B | 4.57% |
| 2022-03-31 | $0.74B | $14.85B | 5.54% |
| 2021-12-31 | $0.94B | $15.00B | 7.96% |
| 2021-09-30 | $1.13B | $14.90B | 11.23% |
| 2021-06-30 | $1.18B | $8.74B | 14.63% |
| 2021-03-31 | $1.07B | $8.76B | 14.20% |
| 2020-12-31 | $0.73B | $7.96B | 10.46% |
| 2020-09-30 | $0.41B | $6.87B | 6.25% |
| 2020-06-30 | $0.30B | $6.64B | 4.53% |
| 2020-03-31 | $0.23B | $6.38B | 3.52% |
| 2019-12-31 | $0.23B | $6.54B | 3.57% |
| 2019-09-30 | $0.23B | $6.49B | 3.75% |
| 2019-06-30 | $0.25B | $6.40B | 4.14% |
| 2019-03-31 | $0.25B | $6.09B | 4.14% |
| 2018-12-31 | $0.24B | $5.98B | 3.98% |
| 2018-09-30 | $0.13B | $5.86B | 2.10% |
| 2018-06-30 | $0.14B | $5.96B | 2.44% |
| 2018-03-31 | $0.28B | $6.13B | 5.19% |
| 2017-12-31 | $0.29B | $6.09B | 5.93% |
| 2017-09-30 | $0.40B | $4.74B | 8.89% |
| 2017-06-30 | $0.37B | $4.61B | 8.35% |
| 2017-03-31 | $0.23B | $4.34B | 5.28% |
| 2016-12-31 | $0.23B | $4.28B | 5.51% |
| 2016-09-30 | $0.24B | $4.31B | 5.62% |
| 2016-06-30 | $0.23B | $4.19B | 5.64% |
| 2016-03-31 | $0.22B | $4.21B | 5.31% |
| 2015-12-31 | $0.21B | $4.17B | 5.20% |
| 2015-09-30 | $0.18B | $4.03B | 4.30% |
| 2015-06-30 | $0.16B | $4.08B | 4.02% |
| 2015-03-31 | $0.16B | $4.03B | 4.08% |
| 2014-12-31 | $0.16B | $4.13B | 3.94% |
| 2014-09-30 | $0.19B | $3.89B | 4.90% |
| 2014-06-30 | $0.19B | $3.94B | 4.86% |
| 2014-03-31 | $0.17B | $3.97B | 4.34% |
| 2013-12-31 | $0.17B | $3.95B | 4.33% |
| 2013-09-30 | $0.08B | $3.85B | 2.19% |
| 2013-06-30 | $0.07B | $3.81B | 1.92% |
| 2013-03-31 | $0.08B | $3.81B | 2.08% |
| 2012-12-31 | $0.07B | $3.90B | 1.84% |
| 2012-09-30 | $0.00B | $3.89B | 0.08% |
| 2012-06-30 | $0.01B | $3.80B | 0.27% |
| 2012-03-31 | $0.01B | $3.86B | 0.16% |
| 2011-12-31 | $0.01B | $3.86B | 0.23% |
| 2011-09-30 | $0.39B | $3.40B | 11.49% |
| 2011-06-30 | $0.36B | $3.60B | 10.90% |
| 2011-03-31 | $0.39B | $3.31B | 12.15% |
| 2010-12-31 | $0.39B | $3.21B | 12.38% |
| 2010-09-30 | $0.13B | $3.25B | 4.20% |
| 2010-06-30 | $0.13B | $3.15B | 4.30% |
| 2010-03-31 | $0.10B | $3.03B | 3.18% |
| 2009-12-31 | $0.08B | $3.06B | 2.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.658B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.906B | 25.49 |
| Elevance Health (ELV) | United States | $86.723B | 11.19 |
| CVS Health (CVS) | United States | $81.012B | 10.07 |
| Cencora (COR) | United States | $56.449B | 19.64 |
| DiDi Global (DIDIY) | China | $21.556B | 32.71 |
| Natera (NTRA) | United States | $21.537B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.928B | 0.00 |
| Solventum (SOLV) | United States | $12.646B | 13.39 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| ICON (ICLR) | Ireland | $10.521B | 9.78 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Doximity (DOCS) | United States | $9.784B | 45.30 |
| Avantor (AVTR) | United States | $8.797B | 12.78 |
| HealthEquity (HQY) | United States | $8.702B | 42.81 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.662B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.149B | 38.40 |
| Bausch + Lomb (BLCO) | Canada | $4.054B | 23.90 |
| Sotera Health (SHC) | United States | $3.474B | 19.74 |
| Alignment Healthcare (ALHC) | United States | $3.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.026B | 39.35 |
| Concentras Parent (CON) | United States | $2.772B | 16.02 |
| Organon (OGN) | United States | $2.397B | 2.55 |
| Ardent Health Partners (ARDT) | United States | $2.071B | 8.83 |
| GeneDx Holdings (WGS) | United States | $2.032B | 78.26 |
| Premier (PINC) | United States | $1.892B | 14.36 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.512B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.400B | 28.00 |
| Pediatrix Medical (MD) | United States | $1.216B | 9.25 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.995B | 0.00 | |
| CareDx (CDNA) | United States | $0.946B | 14.77 |
| Nutex Health (NUTX) | United States | $0.934B | 14.11 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.57 |
| Embecta (EMBC) | United States | $0.615B | 4.15 |
| LifeMD (LFMD) | United States | $0.555B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 43.75 |
| SBC Medicals (SBC) | United States | $0.532B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.389B | 0.00 |
| Oncology Institute (TOI) | United States | $0.285B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| KindlyMD (NAKA) | United States | $0.136B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.112B | 0.00 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |